Cargando…

S213. CIRCADIAN PATTERNS OF HALLUCINATORY EXPERIENCES IN PATIENTS WITH SCHIZOPHRENIA: POTENTIALS FOR CHRONO-PHARMACOLOGY

Abstract not included.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234380/ http://dx.doi.org/10.1093/schbul/sbaa031.279

Ejemplares similares

S155. DIETARY PATTERNS AND OBESITY IN INDIVIDUALS WITH SCHIZOPHRENIA
por: Amirah Abdul Rashid, Nur, et al.
Publicado: (2020)

S90. A SYSTEMATIC REVIEW AND META-ANALYSIS OF PHARMACOLOGICAL INTERVENTIONS FOR REDUCTION OF WEIGHT GAIN IN PEOPLE WITH SCHIZOPHRENIA: 2019 UPDATE
por: Agarwal, Sri Mahavir, et al.
Publicado: (2020)

S209. DRUG-NAïVE FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDERS: PHARMACOLOGICAL TREATMENT PRACTICES IN INPATIENT UNITS IN HUNAN PROVINCE, CHINA
por: Zhu, Mengran, et al.
Publicado: (2020)

M53. EMOTIONAL SELF-VOICE PROCESSING AND ITS RELATIONSHIP WITH HALLUCINATORY PRONENESS
por: Xanthate Duggirala, Suvarnalata, et al.
Publicado: (2020)

S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA?
por: Breier, Alan, et al.
Publicado: (2020)

S68. DIFFERENTIAL PATTERN OF SOCIAL COGNITION IMPAIRMENT BETWEEN RURAL AND URBAN DWELLING PATIENTS OF SCHIZOPHRENIA AND ITS FUNCTIONAL CORRELATES
por: Ibrahim, Ferose, et al.
Publicado: (2020)

S138. A PRELIMINARY STUDY ON ILLNESS INSIGHT MEASURED BY THE RELATIONSHIP BETWEEN ERN PATTERNS AND MMPI RESULTS IN PATIENTS WITH SCHIZOPHRENIA
por: Park, Min-Hyeon, et al.
Publicado: (2020)

S156. PUBLIC ATTENTION TO CRIME OF SCHIZOPHRENIA AND ITS CORRELATION WITH USE OF MENTAL HEALTH SERVICES IN PATIENTS WITH SCHIZOPHRENIA
por: Park, Hyunwoo, et al.
Publicado: (2020)

S223. DETERMINANTS OF SUSTAINED UNEMPLOYMENT IN FORMERLY EMPLOYED SCHIZOPHRENIA PATIENTS
por: Fundora-Trujillo, Cynthia, et al.
Publicado: (2020)

S233. INTERNALIZED STIGMA IN PATIENTS WITH SCHIZOPHRENIA - A TRANSCULTURAL STUDY
Publicado: (2020)

S40. COMBINING PHARMACOTHERAPY OF BI 425809 WITH COMPUTERISED COGNITIVE TRAINING IN PATIENTS WITH SCHIZOPHRENIA: INITIAL EXPERIENCE OF A LARGE-SCALE MULTICENTRE RANDOMISED CLINICAL TRIAL
por: Hake, Sanjay, et al.
Publicado: (2020)

S78. TIME PREDICTION AND SENSE OF SELF: LACK OF FLEXIBILITY IN PATIENTS WITH SCHIZOPHRENIA
por: Giersch, Anne, et al.
Publicado: (2020)

S50. COGNITION AND EMOTION REGULATION IN SCHIZOPHRENIA PATIENTS WITH A HISTORY OF AGGRESSION
por: Ahmed, Anthony, et al.
Publicado: (2020)

S24. PATHWAYS LINKING ENVIRONMENTAL RISKS, POLYGENIC RISK SCORE TO SCHIZOPHRENIA AND PSYCHOTIC EXPERIENCES IN A BRAZILIAN COHORT OF CHILDREN AND ADOLESCENTS
por: Fonseca, Lais, et al.
Publicado: (2020)

S91. OPIOID USE AND SCHIZOPHRENIA: AN UPDATE
Publicado: (2020)

S49. THE RELATION BETWEEN PROCESSING SPEED AND USAGE OF MOBILE APPLICATIONS IN PATIENTS WITH SCHIZOPHRENIA
por: Hoşgelen, Emine Ilgın, et al.
Publicado: (2020)

S192. EFFECTS OF NICOTINE INTAKE ON NEUROPLASTICITY IN SMOKING AND NON-SMOKING PATIENTS WITH SCHIZOPHRENIA
por: Pross, Benjamin, et al.
Publicado: (2020)

S235. COGNITION AND SOCIAL BEHAVIORS IN SPORTS FOR PATIENTS WITH SCHIZOPHRENIA ENGAGED IN SPORTS HABITS
por: Yoshihara, Yujiro, et al.
Publicado: (2020)

M140. WHAT HAPPENS IN THE BRAIN A FEW SECONDS BEFORE THE ONSET AND OFFSET OF AN HALLUCINATORY EPISODE?
por: Craven, Alexander, et al.
Publicado: (2020)

S198. SELF-DISTURBANCES AND THEIR NEURAL SIGNATURES IN SCHIZOPHRENIA
por: Zaytseva, Yulia, et al.
Publicado: (2020)

S142. NOVEL CONCEPTS OF SOCIAL IMPAIRMENTS IN SCHIZOPHRENIA
por: Bitsch, Florian, et al.
Publicado: (2020)

S158. URBANICITY INDEX AND CORTICAL GYRIFICATION IN SCHIZOPHRENIA
por: Korann, Vittal, et al.
Publicado: (2020)

S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Millgate, Edward, et al.
Publicado: (2020)

S220. DIFFERENTIATING EMPLOYMENT TRAJECTORIES IN SCHIZOPHRENIA: FEATURES OF CURRENT, FORMERLY, AND NEVER EMPLOYED PATIENTS
por: Barone, Katelyn, et al.
Publicado: (2020)

S11. PLASMA LEPTIN AND ANTHRANILIC ACID IN SCHIZOPHRENIA PATIENTS: NEW BIOMARKERS OF PREDISPOSITION TO METABOLIC ABNORMALITIES
por: Steiner, Johann, et al.
Publicado: (2020)

S164. HIPPOCAMPAL CONNECTIVITY IN YOUTH WITH SCHIZOPHRENIA: COMPARISON WITH PATIENTS WITH NMDA RECEPTOR ENCEPHALITIS AND HEALTHY VOLUNTEERS
por: Sugranyes, Gisela, et al.
Publicado: (2020)

S111. A REAL ENVIRONMENT BASED VIRTUAL REALITY APPLICATION TO IMPROVE PHYSICAL HEALTH OF PATIENTS WITH SCHIZOPHRENIA
por: Alptekin, Koksal, et al.
Publicado: (2020)

S214. HEART RATE VARIABILITY PREDICTS CLOZAPINE PLASMA LEVEL IN PATIENTS WITH SCHIZOPHRENIA IN A POLYPHARMACY CONDITION
por: Mi Park, Su, et al.
Publicado: (2020)

S236. QUALITY OF LIFE AND ASSOCIATION WITH SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA SIX YEARS AFTER FIRST EPISODE PSYCHOSES
por: Andersen, Gitte, et al.
Publicado: (2020)

S170. PROGRESSIVE SUBCORTICAL VOLUME LOSS IN TREATMENT-RESISTANT SCHIZOPHRENIA PATIENTS AFTER COMMENCING CLOZAPINE TREATMENT
por: Tronchin, Giulia, et al.
Publicado: (2020)

S237. MODERATORS AND RELATIONSHIPS OF COGNITION AND SUBJECTIVE QUALITY OF LIFE IN SCHIZOPHRENIA
por: Tan, Eric, et al.
Publicado: (2020)

S66. USING UNITIZATION TO CIRCUMVENT RELATIONAL MEMORY DEFICITS IN SCHIZOPHRENIA
por: de Sousa, Ana Elisa Farias, et al.
Publicado: (2020)

S48. INSIGHT VS COGNITION AND SYMPTOMATIC REMISSION AMONG PATIENTS WITH SCHIZOPHRENIA- THE INFLUENCE OF TRAIT VS STATE PHENOMENON?
por: Helldin, Lars, et al.
Publicado: (2020)

S171. EFFECT OF DAOA GENETIC VARIATION ON WHITE MATTER ALTERATION IN CORPUS CALLOSUM IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA
por: Su, Wenjun, et al.
Publicado: (2020)

S72. MCCB COGNITIVE PROFILE IN CHINESE FIRST EPISODE SCHIZOPHRENIA PATIENTS AND SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Lei, Zhao, et al.
Publicado: (2020)

S41. RANDOMISED CONTROLLED TRIAL OF METACOGNITIVE TRAINING COMPARED WITH PSYCHOEDUCATION IN PATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDERS: EFFECTS ON INSIGHT
por: Lopez-Morinigo, Javier-David, et al.
Publicado: (2020)

S54. THE RELATION OF FORMAL THOUGHT DISORDER WITH COGNITIVE FUNCTIONS, GLOBAL AND SOCIAL FUNCTIONING AND QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA
por: Mutlu, Emre, et al.
Publicado: (2020)

S194. CLOZAPINE AND ELECTROCONVULSIVE THERAPY AUGMENTATION IN ADOLESCENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Jeong Park, Kee, et al.
Publicado: (2020)

S149. CHANGES IN FRONTO-PARIETAL CONNECTIVITY IN SCHIZOPHRENIA: TMS AND FNIRS STUDY
por: Ćurčić-Blake, Branislava, et al.
Publicado: (2020)

S168. THE ASSOCIATION BETWEEN MMP-9 AND CHOROID PLEXUS VOLUME IN SCHIZOPHRENIA
por: Seethaler, Magdalena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jled3qolu02tpn180volmvn69k